UK markets closed

Universal Ibogaine Inc (JC4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.01250.0000 (0.00%)
At close: 07:10PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/03/2021
Total revenue
2,224
1,030
1,071
0
0
Cost of revenue
-
-
-
0
-
Gross profit
-
-
-
0
-
Operating expenses
Research development
0
9.212
409.311
0
-
Selling general and administrative
1,113
1,717
4,568
3,795
77.108
Total operating expenses
3,023
3,081
5,817
3,865
77.413
Operating income or loss
-799
-2,051
-4,746
-3,865
-77.413
Interest expense
155.378
153.224
67.742
15.005
-
Total other income/expenses net
-231.262
-186.491
-5,682
12.674
-213.26
Income before tax
-1,186
-2,390
-10,496
-3,867
-290.648
Income from continuing operations
-1,186
-2,390
-10,496
-3,867
-290.648
Net income
-1,186
-2,390
-10,496
-3,867
-290.648
Net income available to common shareholders
-1,186
-2,390
-10,496
-3,867
-290.648
Basic EPS
-0.03
-0.01
-0.06
-0.03
-0.03
Diluted EPS
-0.03
-0.01
-0.06
-0.03
-0.03
Basic average shares
191,030
191,298
185,637
125,190
9,688
Diluted average shares
191,030
191,298
185,637
125,190
9,688